[Survival following surgery for bronchopulmonary cancer. Results after five years].
The authors study the actuarial survival of 253 primary bronchopulmonary cancers operated in Geneva between 1967 and 1976. The overall operative mortality was 9.88%. The overall survival of resections alone was 26.6% at 5 years. The small size of the tumor, the absence of mediastinal extension and an epidermoid histology are the best survival rate factors: 43.2% of stage I cases survive at 5 years against 4.86% of stage III cases. The accidental discovery of as asymptomatic tumor gives a hope of survival of 43.9% at 5 years. Yet again this demonstrates the importance of mass screening by radiophotography. Surgery thus maintains its central role in the treatment of this disease, whilst chemo-, radio- and immunotherapy have not yet revealed their full possibilities.
D000230:Adenocarcinoma / Q000601:surgery; D000328:Adult; D000368:Aged; D001984:Bronchial Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D002277:Carcinoma / Q000601:surgery; D018288:Carcinoma, Small Cell / Q000601:surgery; D002294:Carcinoma, Squamous Cell / Q000601:surgery; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000401:mortality / Q000473:pathology / Q000601:surgery*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011013:Pneumonectomy; D011183:Postoperative Complications / Q000401:mortality*
Survie des cancers bronchopulmonaires opérés. Résultats à 5ans.